Recent Posts
Categories
Tag Archives: Novartis
U.S. sues Novartis, alleging kickbacks to pharmacies
(Reuters) – The U.S. government filed a civil fraud lawsuit against Novartis AG on Tuesday, accusing a unit of the Swiss drug maker of causing the Medicare and Medicaid programs to pay tens of millions of dollars in reimbursements based … Continue reading
U.S. sues Novartis, alleging kickbacks to pharmacies
(Reuters) – The U.S. government filed a civil fraud lawsuit against Novartis AG on Tuesday, accusing a unit of the Swiss drug maker of causing the Medicare and Medicaid programs to pay tens of millions of dollars in reimbursements based … Continue reading
Novartis loses landmark India patent case on Glivec
MUMBAI/NEW DELHI (Reuters) – India’s top court dismissed Swiss drugmaker Novartis AG’s attempt to win patent protection for its cancer drug Glivec, a blow to Western pharmaceutical firms targeting India to drive sales and a victory for local makers of … Continue reading
Novartis says Alcon’s eye drug Jetrea gets EU approval
ZURICH (Reuters) – Novartis said its Alcon unit got a green light from the European Commission for Jetrea, a drug that treats an eye condition that can lead to blindness.
Novartis drug helps patients with rare inflammatory diseases
ZURICH (Reuters) – Novartis’ Ilaris helps reduce patients’ symptoms and the frequency of attacks in two rare inflammatory diseases, mid-stage studies showed, as the Swiss drugmaker looks to expand the use of the medicine.
Posted in Business
Tagged diseases, drug, Helps, inflammatory, Novartis, Patients, rare
Leave a comment
EU body backs Novartis’ Galvus, Eucreas for diabetes indications
ZURICH (Reuters) – European regulators on Friday issued positive opinions for new indications of Novartis AG drugs Galvus and Eucreas in combination with other treatments for type 2 diabetes patients.
Posted in Business
Tagged backs, body, diabetes, Eucreas, Galvus, indications, Novartis
Leave a comment
Novartis argues for Glivec patent at India’s top court
NEW DELHI (Reuters) – Swiss drugmaker Novartis told India’s top court it had demonstrated the improved efficacy of its cancer drug Glivec as the final hearing began on Tuesday of a patent case that could change the rules for the … Continue reading
FDA panel backs Novartis cystic fibrosis drug
WASHINGTON (Reuters) – Drug advisers on Wednesday backed a new form of Novartis AG’s inhaled antibiotic that treats a lung infection linked to cystic fibrosis.
New trial data confirms safety of Novartis drug Lucentis
ZURICH (Reuters) – Switzterland’s Novartis said on Wednesday new data for Lucentis demonstrated the long-term efficacy and safety of the drug and also showed its benefits in treating a new condition, which Novartis will seek approval for.
FDA staff question Novartis cystic fibrosis drug
WASHINGTON (Reuters) – U.S. drug reviewers questioned whether Novartis AG’s experimental inhaled antibiotic powder truly helped cystic fibrosis patients breathe better, according to documents posted by the Food and Drug Administration on its website Friday.